Skip to content

Clinical trials

Completed Hemorrhagic Fever, Ebola trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Fever, Ebola Status: Completed Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20082
20102
20149
201521
20163
20178
20185
20194
20202
20217
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)18
Janssen Vaccines & Prevention B.V.6
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation5
University of Oxford5
London School of Hygiene and Tropical Medicine4
Jiangsu Province Centers for Disease Control and Prevention3
Institut National de la Santé Et de la Recherche Médicale, France2
University of Maryland, Baltimore2
Albert B. Sabin Vaccine Institute1
Alliance for International Medical Action1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Fever, Ebola68
Hemorrhagic Fevers, Viral14
Filoviridae Infections4
Marburg Virus Disease4
Acquired Immunodeficiency Syndrome3
RNA Virus Infections2
Virus Diseases2
Angioedemas, Hereditary1
Communicable Diseases1
Communicable Diseases, Emerging1

Trials

Showing 51 to 68 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.